Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance

Fig. 5

Two nomograms and corresponding results showed the prognostic value of AS events and clinicopathologic data. Nomogram for predicting OS (a) and DFS (d) in the HP GC cohort. Calibration plot of the AS-clinicopathologic nomogram in terms of the agreement between nomogram-predicted and observed 1-, 2-, and 3-years OS (b) and DFS (e) in the HP GC cohort. c, f Decision curve analysis of the AS-clinicopathologic nomogram for 1-, 2-, and 3-years risk in the HP GC cohort. AS alternative splicing, OS overall survival, DFS disease-free survival, HPGC Helicobacter pylori-negative gastric cancer, ROC receiver operating characteristic

Back to article page